Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (3)

2016

  1. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro

    Journal of Endocrinology, Vol. 231, Núm. 2, pp. 135-145

2006

  1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326

2003

  1. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage

    Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481